Clinical Trials on Alzheimer’s Disease

Gene-silencing data for Alzheimer’s by Alnylam, Biogen | Pharma News

Alnylam, Biogen show gene-silencing data for Alzheimer’s therapies

Anika Sharma

This week, Alnylam and Biogen took a significant step toward redefining the landscape of Alzheimer’s disease treatment by revealing promising ...